New Key Statistics Module, Z-Score and F-Score
NSE:VIVIMEDLAB Key Ratios
| Market Cap ₹ M | 563.82 |
| Enterprise Value ₹ M | 4,459.77 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.82 |
| Price/Free Cash Flow | 8.58 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) ₹ M | 699.00 |
| EPS (TTM) ₹ | -21.28 |
| Beneish M-Score | -9.23 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.58 |
| EV-to-EBITDA | -3.05 |
| PEG | -- |
| Shares Outstanding M | 82.91 |
| Net Margin (%) | -252.14 |
| Operating Margin % | -255.03 |
| Pre-tax Margin (%) | -251.95 |
| Quick Ratio | 0.35 |
| Current Ratio | 0.37 |
| ROA % (ttm) | -20.38 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -18.68 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.07 |
NSE:VIVIMEDLAB Number of Guru Trades
NSE:VIVIMEDLAB Volume of Guru Trades
Gurus Latest Trades with NSE:VIVIMEDLAB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NSE:VIVIMEDLAB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers